Search Results - "Febrian, Muhammad Basit"

Radiolabelling and In Silico Evaluation of ¹³¹I-Pentagamavunone-0 for Therapeutic and Diagnostic Compounds.

Authors: Febrian, Muhammad Basit Munir, Miftakul Utomo, Rohmad Yudi et al.

Source: Indonesian Journal of Pharmacy / Majalah Farmasi Indonesia. Jul-Sep2025, Vol. 36 Issue 3, p445-457. 13p.

A dual approach to cancer therapy and diagnosis: in vitro, in vivo, and in silico study of ¹³¹I-labeled pentagamavunon-0.

Authors: Forentin, Alfian Mahardika Munir, Miftakul Febrian, Muhammad Basit et al.

Source: Journal of Radioanalytical & Nuclear Chemistry. May2025, Vol. 334 Issue 5, p3393-3407. 15p.

Radiosynthesis of [131I]I-Hesperidin: Optimization, physicochemical profiling, and computational insights for targeted radiopharmaceuticals.

Authors: Munir, Miftakul Forentin, Alfian Mahardika Febrian, Muhammad Basit et al.

Source: Applied Radiation & Isotopes. Nov2025, Vol. 225, pN.PAG-N.PAG. 1p.

Subjects: Hesperidin, Radiopharmaceuticals, Radioactive tracers, HER2 protein, Epidermal growth factor receptors, Iodine, Radiolabeling, Absorption (Physiology)

The stability study of bone implant: The biodistribution of Scandium-46 labeled hydroxyapatite-collagen-chitosan composite in rat model.

Authors: Mahendra, Isa Kurniawan, Ahmad Febrian, Muhammad Basit et al.

Source: AIP Conference Proceedings. 2021, Vol. 2338/2381 Issue 1, p1-4. 4p.